INTRAVESICAL GEMCITABINE IN THE TREATMENT OF INTERMEDIATE-RISK SUPERFICIAL TRANSITIONAL CELL CARCINOMA (TCC) OF THE BLADDER: A MARKER LESION STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles